Table 1 |
|||
|
Patient information |
|||
|
Patient |
Immunosuppressants |
Daily dose (mg) |
Length of exposure (years) |
|
|
|||
|
WT |
Mycophenolate/prednisone/tacrolimus |
3.5/10/1,000 |
4 |
|
SLE |
Mycophenolate/prednisone/tacrolimus |
3/7/1,000 |
11 |
|
ADPKD |
Mycophenolate/tacrolimus |
3.5/2,000 |
1 |
|
|
|||
|
ADPKD, autosomal-dominant polycystic kidney disease; SLE, system lupus erythematosus; WT, Wilms tumor. |
|||
|
Thatava et al. Stem Cell Research & Therapy 2011 2:48 doi:10.1186/scrt89 |
|||
